VELUON LTD

Active Birmingham
2 employees website.com
Life sciences and medical technology
V

VELUON LTD

Founded 31 Jul 2015 Active Birmingham, United Kingdom 2 employees website.com
Life sciences and medical technology

Previous Company Names

OPTRAPHARM INSTRUMENTATION LTD 31 Jul 2015 — 1 Aug 2019
Accounts Submitted 18 Dec 2025 Next due 30 Sept 2026 4 months remaining
Confirmation
Net assets £367K £31K 2024 year on year
Total assets £702K £49K 2024 year on year
Total Liabilities £335K £18K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Unit 15 Flexspace Middlemore Road Birmingham B21 0AL United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for VELUON LTD (09712136), an active life sciences and medical technology company based in Birmingham, United Kingdom. Incorporated 31 Jul 2015. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2016–2024)

Cash in Bank

£630.11k

Increased by £66.47k (+12%)

Net Assets

£367.43k

Decreased by £31.13k (-8%)

Total Liabilities

£334.70k

Decreased by £18.14k (-5%)

Turnover

N/A

Employees

2

Debt Ratio

48%

Increased by 1 (+2%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 300 Shares £99.99 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
18 Dec 2025150£49.995£0.333
18 Dec 2025150£49.995£0.333

Officers

Officers

2 active 1 resigned
Status
Jordan Mark AspleyDirectorBritishEngland3325 Mar 2019Active
Thomas Edward DrewDirectorBritishEngland4331 Jul 2015Active

Shareholders

Shareholders (3)

Captivara Limited
33.3%
Thomas Edward Drew
33.3%

Persons with Significant Control

Persons with Significant Control (3)

3 Active 1 Ceased

Jordan Mark Aspley

British

Active
Notified 31 Jul 2019
Residence England
DOB March 1993
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Thomas Edward Drew

British

Active
Notified 6 Apr 2016
Residence England
DOB May 1983
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Captivara Limited

United Kingdom

Active
Notified 18 Jun 2023
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Suraj Kumar Sudera

Ceased 18 Jun 2023

Ceased

Group Structure

Group Structure

CAPTIVARA LIMITED united kingdom
VELUON LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
19 Jan 2026OfficersAppointment of Mr Michael Olaf Procter as director on 16 Jan 2026
16 Jan 2026OfficersAppointment of Mr Robert Phipps as director on 16 Jan 2026
9 Jan 2026IncorporationMemorandum Articles
9 Jan 2026ResolutionResolutions
5 Jan 2026CapitalAllotment of shares (GBP 199.98) on 18 Dec 2025
19 Jan 2026 Officers

Appointment of Mr Michael Olaf Procter as director on 16 Jan 2026

16 Jan 2026 Officers

Appointment of Mr Robert Phipps as director on 16 Jan 2026

9 Jan 2026 Incorporation

Memorandum Articles

9 Jan 2026 Resolution

Resolutions

5 Jan 2026 Capital

Allotment of shares (GBP 199.98) on 18 Dec 2025

Recent Activity

Latest Activity

Appointment of Mr Michael Olaf Procter as director on 16 Jan 2026

4 months ago on 19 Jan 2026

Appointment of Mr Robert Phipps as director on 16 Jan 2026

4 months ago on 16 Jan 2026

Memorandum Articles

4 months ago on 9 Jan 2026

Resolutions

4 months ago on 9 Jan 2026

Allotment of shares (GBP 199.98) on 18 Dec 2025

4 months ago on 5 Jan 2026